Retinal Consultants Medical Group

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Diabetic eye disease4 trials
• Macular degeneration1 trial

Phase

• Phase 11 trial
• Phase 1/21 trial
• Phase 21 trial
• Phase 2/31 trial
• Phase 31 trial

Status

• Completed3 trials
• Active, not recruiting2 trials

Lead sponsor

• Genentech, Inc.2 trials
• EyePoint Pharmaceuticals, Inc.1 trial
• Greater Houston Retina Research1 trial
• Oculis1 trial

Running trials

• Active, not recruiting

  A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56

  NCT06683742· Phase 3· EyePoint Pharmaceuticals, Inc.· Source

• Active, not recruiting

  A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7497372 in Participants With Diabetic Macular Edema (DME)

  NCT06847854· Phase 1· Genentech, Inc.· Source

Closed trials

• Completed

  Safety and Efficacy of Faricimab in Patients With NPDR

  NCT05681884· Phase 2· Greater Houston Retina Research· Source

• Completed

  A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema

  NCT06850922· Phase 1/2· Genentech, Inc.· Source

• Completed

  A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 1)

  NCT05066997· Phase 2/3· Oculis· Source